Granahan Investment Management - KEZAR LIFE SCIENCES INC ownership

KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 104 filers reported holding KEZAR LIFE SCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of KEZAR LIFE SCIENCES INC
ValueSharesWeighting
Q4 2023$1,805,910
+4.5%
1,906,175
+31.2%
0.06%
-3.2%
Q3 2023$1,728,544
-62.8%
1,452,558
-23.5%
0.06%
-56.6%
Q2 2023$4,652,597
+32.6%
1,899,019
+69.4%
0.14%
+33.6%
Q1 2023$3,509,782
-27.8%
1,121,336
+62.4%
0.11%
-28.2%
Q4 2022$4,860,282
+26.2%
690,381
+54.3%
0.15%
+18.3%
Q3 2022$3,852,000
+68.7%
447,418
+62.0%
0.13%
+61.5%
Q2 2022$2,284,000
-19.0%
276,164
+62.8%
0.08%
+11.4%
Q1 2022$2,820,000
+45.1%
169,685
+46.0%
0.07%
+75.0%
Q4 2021$1,944,000116,2620.04%
Other shareholders
KEZAR LIFE SCIENCES INC shareholders Q2 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 828,711$497,2270.94%
Stonepine Capital Management, LLC 1,050,452$630,2710.58%
Acuitas Investments, LLC 986,785$592,0710.32%
SPHERA FUNDS MANAGEMENT LTD. 2,051,676$1,231,0060.17%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,167,591$4,300,5550.16%
Avidity Partners Management LP 5,026,000$3,015,6000.13%
ADAR1 Capital Management, LLC 1,086,498$651,8990.12%
Affinity Asset Advisors, LLC 1,761,778$1,057,0670.12%
Ikarian Capital, LLC 868,992$521,3950.09%
Orbimed Advisors 1,927,000$1,156,2000.02%
View complete list of KEZAR LIFE SCIENCES INC shareholders